![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
Alnylam and Ascletis collaborate to develop ALN-VSP for liver cancers in China
Alnylam Pharmaceuticals and Ascletis Pharmaceuticals have entered into a partnership to develop a systemically...
Takeda signs Omontys injection supply contract with Fresenius
Takeda Pharmaceuticals America (TPA) has signed a contract to supply Omontys injection to Fresenius...
Boehringer, Eli Lilly to launch diabetes drug in India
Boehringer Ingelheim India and Eli Lilly India is set to launch Linagliptin (brand name...
BioBlocks, Full Spectrum to develop new small molecule therapeutics
Full Spectrum Genetics and BioBlocks have signed an agreement to find new Small Molecule...
Mylan receives FDA approval for generic Lipitor ANDA
Mylan Laboratories, formerly Matrix Laboratories, has gained final FDA approval for its abbreviated new...
Cellectricon introduces Cellaxess discovery platform
Cellectricon has launched a new Cellaxess elektra discovery platform for automated electric field manipulation...
Aegis wins US patent for octreotide formulations
Aegis Therapeutics has received US patent covering pharmaceutical composition of octreotide. ...
Cellectis introduces human iPS derived hepatocyte product
Cellectis stem cells, a business unit of Cellectis Group, has introduced hiPS-HEP, a human...
Antares, Watson Pharmaceuticals launch Gelnique 3% in US
Antares Pharma and Watson Pharmaceuticals have introduced Gelnique 3% (oxybutynin) gel 3%, for the...
Meridian, Teva settle epinephrine auto-injector pending patent litigation
Meridian Medical Technologies, a Pfizer subsidiary, and Teva have entered into a settlement agreement...